Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adult Glioblastoma
|
98 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.020 | 0.500 | 2 | 2007 | 2017 | |||||
Childhood Glioblastoma
|
98 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.020 | 0.500 | 2 | 2007 | 2017 | |||||
Glioblastoma
|
157 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.020 | 0.500 | 2 | 2007 | 2017 | |||||
Glioblastoma Multiforme
|
160 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.020 | 0.500 | 2 | 2007 | 2017 | |||||
Non-Small Cell Lung Carcinoma
|
601 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.020 | 1.000 | 2 | 2012 | 2015 | |||||
Brain Neoplasms
|
85 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Carcinogenesis
|
355 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Carcinoma of lung
|
995 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Childhood Osteosarcoma
|
151 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Glioma
|
283 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Malignant neoplasm of lung
|
1000 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of pancreas
|
238 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Mammary Neoplasms
|
78 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Neoplasms
|
1571 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Osteosarcoma
|
155 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Osteosarcoma of bone
|
151 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Pancreatic carcinoma
|
236 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Primary malignant neoplasm of lung
|
981 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Tumor Progression
|
72 | 0.716 | 0.160 | 7 | 106867593 | missense variant | T/G | snv | 8.4E-06 | 0.010 | 1.000 | 1 | 2014 | 2014 |